Innovative Medicine Initiatives – Horizon 2020 Open Calls
16/02/2017
news@umfiasi.ro (254 articole)
0 comentarii
Distribuie

Innovative Medicine Initiatives – Horizon 2020 Open Calls

IMI2-2016-10-01: Understanding hypoglycaemia: the underlying mechanisms and addressing clinical determinants as well as consequences for people with diabetes by combining databases from clinical trials

Status: Open

Publication date: 21 December 2016

Types of action: IMI2-RIA Research and Innovation action

DeadlineModel: two-stage

Opening date: 04 January 2017

Deadline: 28 March 2017 17:00:00 (Brussels time)

2nd stage Deadline: 14 September 2017 17:00:00 (Brussels time)

IMI2-2016-10-02: How Big Data could support better diagnosis and treatment outcomes for Prostate Cancer

Status: Open

Publication date: 21 December 2016

Types of action: IMI2-RIA Research and Innovation action

DeadlineModel: two-stage

Opening date: 04 January 2017

Deadline: 28 March 2017 17:00:00 (Brussels time)

2nd stage Deadline: 14 September 2017 17:00:00 (Brussels time)

IMI2-2016-10-03: Improving the care of patients suffering from acute or chronic pain

Status: Open

Publication date: 21 December 2016

Types of action: IMI2-RIA Research and Innovation action

DeadlineModel: two-stage

Opening date: 04 January 2017

Deadline: 28 March 2017 17:00:00 (Brussels time)

2nd stage Deadline: 14 September 2017 17:00:00 (Brussels time)Web: https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/imi2-2016-10-03.html

IMI2-2016-10-04: Creation of a pan-European Paediatric Clinical Trials Network

Status: Open

Publication date: 21 December 2016

Types of action: IMI2-RIA Research and Innovation action

DeadlineModel: two-stage

Opening date: 04 January 2017

Deadline: 28 March 2017 17:00:00 (Brussels time)

2nd stage Deadline: 14 September 2017 17:00:00 (Brussels time)

IMI2-2016-10-05: Biomanufacturing 2020: Development of Innovative high throughput analytical tools and methods to characterize cell culture fluid during development and commercial cell culture processes

Status: Open

Publication date: 21 December 2016

Types of action: IMI2-RIA Research and Innovation action

DeadlineModel: two-stage

Opening date: 04 January 2017

Deadline: 28 March 2017 17:00:00 (Brussels time)

2nd stage Deadline: 14 September 2017 17:00:00 (Brussels time)

IMI2-2016-10-06: Unlocking the Solute Carrier Gene-Family for Effective New Therapies (Unlock SLCs)

Status: Open

Publication date: 21 December 2016

Types of action: IMI2-RIA Research and Innovation action

DeadlineModel: two-stage

Opening date: 04 January 2017

Deadline: 28 March 2017 17:00:00 (Brussels time)

2nd stage Deadline: 14 September 2017 17:00:00 (Brussels time)

IMI2-2016-10-07: Patient perspectives in medicines lifecycle

Status: Open

Publication date: 21 December 2016

Types of action: IMI2-RIA Research and Innovation action

DeadlineModel: two-stage

Opening date: 04 January 2017

Deadline: 28 March 2017 17:00:00 (Brussels time)

2nd stage Deadline: 14 September 2017 17:00:00 (Brussels time)

IMI2-2016-10-08: Personalised medicine approaches in autism spectrum disorders

Status: Open

Publication date: 21 December 2016

Types of action: IMI2-RIA Research and Innovation action

DeadlineModel: two-stage

Opening date: 04 January 2017

Deadline: 28 March 2017 17:00:00 (Brussels time)

2nd stage Deadline: 14 September 2017 17:00:00 (Brussels time)

 

 

Taguri apel, cercetare
news@umfiasi.ro

news@umfiasi.ro

News@umfiasi.ro este portalul de știri al Universității de Medicină și Farmacie “Grigore T. Popa” Iași.

Comentarii

Nu exista comentarii Fii primul care comenteaza acest articol!

Scrie un comentariu

Reguli pentru un dialog civilizat: Comentariile se vor incadra in tematica articolului si se vor referi la articol, si NU la autorul acestuia. Va rugam insistent sa folositi un limbaj civilizat si o limba romana curata si corecta. Comentariile care nu respecta aceste doua reguli simple NU vor fi publicate.

Campurile marcate cu * sunt obligatorii